共同设计的技术和患有痴呆症的人:定性系统审查
Wendy Moyle1, Deepa Sriram1, Jenny Murfield2
1School of Nursing and Midwifery, Griffith University, Brisbane, Australia.
Contemporary nurse
|May 5, 2025
概括
共同设计痴呆症技术是有益的,但痴呆症患者通常不参与早期设计阶段. 为了有效的技术开发和使用,需要更多的参与.
科学领域:
- 老年学是一门学科.
- 人与计算机的交互
- 医疗信息学 医疗信息学
背景情况:
- 与痴呆症患者共同设计技术可以创建符合他们的需求和偏好的产品.
- 有效的技术开发需要在整个设计过程中了解用户的观点.
研究的目的:
- 系统地评估共同设计的技术用于痴呆的使用.
- 评估痴呆症患者在共同设计研究中的参与程度.
- 分析共同设计对技术开发和使用的影响.
主要方法:
- 按照乔安娜·布里格斯的方法进行定性系统审查.
- 搜索了五个电子数据库 (CINAHL,EMBASE,PubMed,PsycINFO,Medline) 在2023年11月之前发表的定性论文.
- 四名独立审稿人使用Covidence对文章进行了选,使用JBI质量评估工具进行了质量评估.
主要成果:
- 包括9项主要研究,涉及3个国家的354名参与者.
- 应用程序是开发的最受欢迎的技术,但大多数都处于早期开发阶段.
- 参与者的参与主要是咨询和可用性/可接受性测试,而不是概念化.
结论:
- 共设计用于痴呆症技术,但由于用户参与概念化和设计不足,其有效性受到限制.
- 研究人员,护理专业人员和开发人员应该采用共同设计作为标准实践,并使用一致的术语.
相关概念视频
Documentation in Long-Term and Home Healthcare Setting
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...


